APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 44 filers reported holding APTINYX INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $147,000 | -75.5% | 263,954 | 0.0% | 0.00% | – |
Q1 2022 | $600,000 | -14.9% | 263,954 | 0.0% | 0.00% | – |
Q4 2021 | $705,000 | +14.1% | 263,954 | 0.0% | 0.00% | – |
Q3 2021 | $618,000 | +12260.0% | 263,954 | +15166.3% | 0.00% | – |
Q2 2021 | $5,000 | -99.2% | 1,729 | -99.2% | 0.00% | – |
Q1 2021 | $635,000 | -42.8% | 211,639 | -34.1% | 0.00% | – |
Q4 2020 | $1,111,000 | +61.2% | 321,137 | +54.2% | 0.00% | – |
Q3 2020 | $689,000 | +5.8% | 208,288 | +33.6% | 0.00% | – |
Q2 2020 | $651,000 | +46.3% | 155,866 | -24.4% | 0.00% | – |
Q1 2020 | $445,000 | -17.4% | 206,083 | +30.9% | 0.00% | – |
Q4 2019 | $539,000 | -24.5% | 157,405 | -23.0% | 0.00% | – |
Q3 2019 | $714,000 | +42.2% | 204,518 | +34.1% | 0.00% | – |
Q2 2019 | $502,000 | -43.8% | 152,544 | -30.8% | 0.00% | – |
Q1 2019 | $893,000 | -66.6% | 220,551 | +36.4% | 0.00% | -100.0% |
Q4 2018 | $2,675,000 | -45.5% | 161,726 | -4.5% | 0.00% | 0.0% |
Q3 2018 | $4,906,000 | +29.5% | 169,408 | +8.1% | 0.00% | 0.0% |
Q2 2018 | $3,788,000 | – | 156,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
Orbimed Advisors | 538,500 | $300,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |